Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 30 (4) , 509-519
- https://doi.org/10.1016/s0093-7754(03)00250-1
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibodyBone Marrow Transplantation, 2001
- Etanercept in graft-versus-host diseaseBone Marrow Transplantation, 2000
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen densityInternational Immunology, 1999
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- A TOXICITY STUDY OF TRIMETREXATE USED IN COMBINATION WITH CYCLOSPORINE AS ACUTE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN HLA-MISMATCHED, RELATED DONOR BONE MARROW TRANSPLANTSTransplantation, 1995
- TREATMENT OF MODERATE AND SEVERE ACUTE GVHD AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1994
- Acute and chronic graft-versus-host diseaseCurrent Opinion in Oncology, 1993
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- FAILURE OF EARLY ADMINISTRATION OF ANTITHYMOCYTE GLOBULIN TO LESSEN GRAFT-VERSUS-HOST DISEASE IN HUMAN ALLOGENEIC MARROW TRANSPLANT RECIPIENTSTransplantation, 1981